Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCvc Ig Gbp Regulatory News (CVCG)

Share Price Information for Cvc Ig Gbp (CVCG)

Share Price is delayed by 15 minutes
Get Live Data
117.50    0.50 (0.43%)
Bid:
117.00
Ask:
118.50
Spread: 1.50 (1.282%)
Market Cap: £327.59m
CVCG Live PriceLast checked at - London Stock Exchange

Intraday Cvc Ig Gbp Share Chart

Notice of EGM

23 Sep 2025 14:34

RNS Number : 4921A
CVC Income & Growth Limited
23 September 2025
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM, THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA), AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA, IN ANY MEMBER STATE OF THE EEA OR IN ANY OTHER JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL.

This announcement is not an offer to sell, or a solicitation of an offer to acquire, securities in the United States or in any other jurisdiction in which the same would be unlawful. Neither this announcement nor any part of it shall form the basis of or be relied on in connection with or act as an inducement to enter into any contract or commitment whatsoever.

 

Legal Entity Identifier: 213800Z42Y242CIWJ785

 

 

23 September 2025

 

 

 

CVC Income & Growth Limited

 

Proposals to authorise the Board to issue New Shares

 

Notice of Extraordinary General Meeting

 

 

The Board of CVC Income & Growth Limited (the "Company") announces that it has today published a circular (the "Circular") to convene an extraordinary general meeting (the "EGM") to allow Shareholders to consider and, if thought fit, approve the issue, or sale from treasury, on a non-pre-emptive basis of up to such number of New Shares that represents in total 20 per cent. of the Company's issued share capital (excluding any shares held in treasury) as at the close of the EGM (the "Proposals").

 

Background to, and rationale for, the Proposals

 

At the 2025 AGM, Shareholders granted the Directors authority to allot and issue, on a non-pre-emptive basis, up to 20 per cent. in aggregate of the issued share capital of the Company at that time of the 2025 AGM (excluding any shares held in treasury). The 2025 AGM Authority was granted for the period until the conclusion of the 2026 AGM (unless previously renewed, varied or revoked by the Company at a general meeting).

 

Since the beginning of 2025, the Sterling Shares have traded at an average premium to the Net Asset Value per Sterling Share of 0.36 per cent. and the Company has sold from treasury over 25.2 million Sterling Shares since the 2025 AGM at a premium to the prevailing NAV per Share, raising over £29.8 million of new capital.

 

There has been sustained demand for Shares from a wide range of investors, including an increasing number of retail investors. As a result the Directors have only limited authority to issue up to 16.4 million additional Shares on a non-pre-emptive basis, which represents 6.7 per cent. of the issued share capital of the Company. If the current rate of issuance were to continue, the 2025 AGM Authority would be expected to be fully utilised in advance of the 2026 AGM, where the renewal of such authority is expected to be sought.

 

In light of the continuing demand for the Shares, and having regard to managing the premium at which the Shares trade as well as the benefits of growing the Company's asset base, the Board is seeking further authority from Shareholders generally to disapply pre-emption rights:

·

in relation to the issue of such number of New Shares as represents 10 per cent. of the Company's issued share capital (excluding any shares held in treasury) as at the close of the EGM (the "First General Allotment Authority"); and

 

·

in addition to the First General Authority, in relation to the issue of such further number of New Shares as represents 10 per cent. of the issued share capital (excluding any shares held in treasury) as at the close of the EGM (the "Second General Allotment Authority", together with the First General Allotment Authority, the "General Allotment Authorities"),

 

in each case, with such authority to expire at the conclusion of the 2026 AGM (unless previously renewed, varied or revoked by the Company at a general meeting).

 

The Resolutions are being put forward to ensure the Company can continue to meet ongoing demand for Shares from investors and to manage the premium at which the Shares trade.

 

As at the Latest Practicable Date, the Company currently holds 208,460,159 Sterling Shares and 60,149,978 Euro Shares in treasury.

 

The disapplication of pre-emption rights for the purposes of the General Authorities is proposed through two separate Special Resolutions on the basis that they are both a renewal of the 2025 AGM Authority. Each of the General Allotment Authorities is in addition to, and not in place of, the authority set out in the other General Allotment Authority and any remaining authority under the 2025 AGM Authority.

 

Benefits of the Proposals

 

The Board believes that the Proposals, once implemented, should have the following benefits for Shareholders:

 

·

maintain the Company's ability to issue Shares to better manage the premium at which the Shares trade to their Net Asset Values per Share from time to time;

 

·

potential to enhance the Net Asset Values per Share of Existing Shares through new issuance at a premium to Net Asset Values per Share, after the costs related to the issuance have been deducted;

 

·

diversifying and growing the Company's Shareholder base which, in turn, may generate greater liquidity in the Shares;

 

·

greater scope to invest and, accordingly, enable the Investment Vehicle Manager to develop and further diversify the Investment Vehicle's portfolio;

 

·

provide the Company with the ability to raise additional capital so that it is able to take advantage of investment opportunities as and when they arise in the future (which in turn may increase the NAV and lead to a reduction in management fees); and

 

·

a reduction of the total expense ratio per Share by spreading the Company's fixed running costs over a larger capital base.

 

Extraordinary General Meeting

 

The formal notice convening the EGM, to be held at the offices of CVC Income & Growth Limited, IFC 1, The Esplanade, St Helier, Jersey, JE1 4BP at 11:00 a.m. on 13 October 2025, is set out at Part III of the Circular. The Notice of General Meeting includes the full text of the Resolutions.

 

 

Expected Timetable

 

Publication of this Circular

23 September 2025

Latest time and date for receipt of Proxy Appointments for the EGM

11:00 a.m. on 9 October 2025

EGM

11:00 a.m. on 13 October 2025

Announcement of the results of the EGM

13 October 2025

 

All references to times in this document are London times unless otherwise stated. Each of the times and dates in this timetable (other than in relation to the EGM) may be extended or brought forward. Any revisions to the times and dates referred to above and elsewhere in this Circular will be notified to Shareholders by public announcement.

Terms used and not defined in this announcement shall have the meanings given to them in the Circular.

 

A copy of the Circular has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism. A copy of this Circular will be available for inspection on the Company's website at https://ig.cvc.com/investor-information/rns-updates/ and at the registered office of the Company at IFC 1, The Esplanade, St Helier, Jersey JE1 4BP during normal business hours on any Business Day, from the date of this Circular until the conclusion of the EGM, and at the place of the EGM for at least 15 minutes prior to, and during, the EGM.

 

Enquiries:

 

CVC Income & Growth Limited: c/o +44 1534 815200Robert Kirkby

 

Winterflood Securities Limited +44 (0) 20 3100 0000

Neil Morgan

 

BNP Paribas S.A., Jersey Branch +44 (0) 1534 813800

Company Secretary

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOGPKNBNNBKDBCB
Date   Source Headline
1st Jul 20265:16 pmRNSIssue of Equity
1st Jul 20269:48 amRNSTotal Voting Rights
30th Jun 20264:48 pmRNSNet Asset Value Month End 29 May 2026
25th Jun 202612:35 pmRNSNet Asset Value Weekly to 19 Jun 2026
19th Jun 20263:52 pmRNSJULY 2026 SHARE CONVERSION - REPLACEMENT
19th Jun 202612:10 pmRNSNet Asset Value Weekly to 12 Jun 2026
18th Jun 20262:37 pmRNSIssue of Equity
18th Jun 202611:48 amRNSJULY 2026 SHARE CONVERSION
11th Jun 20263:15 pmRNSNet Asset Value Weekly to 05 Jun 2026
9th Jun 20264:36 pmRNSIssue of Equity
5th Jun 202612:02 pmRNSNet Asset Value Weekly to 29 May 2026
4th Jun 20264:55 pmRNSIssue of Equity
1st Jun 202612:05 pmRNSNet Asset Value Weekly to 22 May 2026
1st Jun 202610:11 amRNSTotal Voting Rights
29th May 20265:20 pmRNSPUBLICATION OF MONTHLY REPORT
27th May 20264:12 pmRNSIssue of Equity
26th May 20264:51 pmRNSNet Asset Value Month End 30 Apr 2026
21st May 202610:15 amRNSNet Asset Value Weekly to 15 May 2026
15th May 20262:44 pmRNSTotal Voting Rights
14th May 20266:00 pmRNSNet Asset Value Weekly to 08 May 2026
12th May 20262:55 pmRNSNet Asset Value Weekly to 01 May 2026
12th May 20262:51 pmRNSIssue of Equity
7th May 202612:42 pmRNSMARCH 2026 TENDER - PURCHASE OF SHARES
1st May 202610:15 amRNSNet Asset Value Weekly to 24 Apr 2026
1st May 20269:31 amRNSTotal Voting Rights
29th Apr 20263:16 pmRNSPUBLICATION OF MONTHLY REPORT
28th Apr 20262:24 pmRNSDividend Declaration
28th Apr 20261:05 pmRNSResults of 2026 Annual General Meeting
27th Apr 20265:03 pmRNSMarch 2026 Tender Price
27th Apr 20263:44 pmRNSNet Asset Value Month End 31 Mar 2026
24th Apr 20261:25 pmRNSNet Asset Value Weekly to 17 Apr 2026
21st Apr 20264:15 pmRNSMarch 2026 Tender Price
21st Apr 20263:52 pmRNSIssue of Equity
16th Apr 20265:25 pmRNSNet Asset Value Weekly to 10 Apr 2026
10th Apr 20265:40 pmRNSNet Asset Value Weekly to 02 Apr 2026
10th Apr 20261:57 pmRNSNotice of 2026 Annual General Meeting
7th Apr 202610:40 amRNSNet Asset Value Weekly to 27 Mar 2026
1st Apr 202610:00 amRNSTotal Voting Rights
30th Mar 202612:20 pmRNSNet Asset Value Weekly to 20 Mar 2026
25th Mar 202610:59 amRNSPublication of Monthly Report
24th Mar 20267:00 amRNS2025 Annual Report and Financial Statements
20th Mar 20264:01 pmRNSNet Asset Value Month End 27 Feb 2026
19th Mar 20266:00 pmRNSNet Asset Value Weekly to 13 Mar 2026
17th Mar 20263:42 pmRNSShare Price Movement Update
6th Mar 20264:10 pmRNSNet Asset Value Weekly to 27 Feb 2026
4th Mar 20262:32 pmRNSPUBLICATION OF MONTHLY REPORT
3rd Mar 202611:10 amRNSNet Asset Value Weekly to 20 Feb 2026
2nd Mar 202612:27 pmRNSNet Asset Value Month End 30 Jan 2026
2nd Mar 202610:21 amRNSTotal Voting Rights
26th Feb 20265:13 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.